Papers/PMID:38306888
Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.
Multiple sclerosis and related disorders2024The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
crocin-1 — decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”
Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 15 mg crocin tablet twice daily (30 mg/day)
- Population
- Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.2024PMID:38306888Permalink